(Q24338664)

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Latent protein LANA2 from Kaposi's sarcoma-associated herpesvirus interacts with 14-3-3 proteins and inhibits FOXO3a transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

The Myc/Max/Mad network and the transcriptional control of cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Myc translocations in B cell and plasma cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Lymphoma and the control of B cell growth and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Reversible tumorigenesis by MYC in hematopoietic lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

21 January 2018

Myc and the cell cycle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

New Myc-interacting proteins: a second Myc network emerges

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

The Myc:Max protein complex and cell growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

A novel transrepression pathway of c-Myc. Recruitment of a transcriptional corepressor complex to c-Myc by MM-1, a c-Myc-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Distinct localizations and repression activities of MM-1 isoforms toward c-Myc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Association of acetylated histones with paternally expressed genes in the Prader--Willi deletion region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Identification of CDK4 as a target of c-MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Myc and Max proteins possess distinct transcriptional activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

ATP-dependent remodeling and acetylation as regulators of chromatin fluidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Repression of the c-fms gene in fibroblast cells by c-Myc-MM-1-TIF1beta complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

ORF73 of herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor proteins p53 and pRb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

KSHV vFLIP is essential for the survival of infected lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

7 January 2021

p53 inhibition by the LANA protein of KSHV protects against cell death

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

7 January 2021

Recruitment of multiple interferon regulatory factors and histone acetyltransferase to the transcriptionally active interferon a promoters

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

7 January 2021

Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

7 January 2021

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706430200

7 January 2021

Identifiers

DOI

10.1074/JBC.M706430200

1 reference

Consolidated OpenCitations Corpus – April 2017

4475535

4475535

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference